Your cart is currently empty.
Zepbound and Ozempic are two of the most talked-about GLP-1 medications in 2025. Both are used to treat obesity and type 2 diabetes, but they differ in ingredients, pricing, and effectiveness. If you’re deciding between the two, here’s a complete breakdown to help you make the right choice.
1. Key Differences at a Glance
- Ozempic contains semaglutide, a GLP-1 receptor agonist.
- Zepbound contains tirzepatide, which mimics both GLP-1 and GIP hormones.
- Ozempic was first approved for diabetes; Zepbound is FDA-approved for weight loss specifically.
2. Which Helps You Lose More Weight?
Zepbound typically produces greater weight loss compared to Ozempic:
- Zepbound users have lost up to 22.5% of body weight in trials
- Ozempic users average around 15% body weight loss
Why? Tirzepatide (Zepbound) targets two hunger hormones, not just one, leading to stronger appetite suppression and better metabolic results.
3. Cost Without Insurance
If you’re paying out of pocket:
- Ozempic: ~$1,200/month
- Zepbound: ~$1,300–$1,500/month
💡 But with telehealth providers like Meya, you can access compounded versions of these medications for just $196/month, no insurance required.
4. Side Effects: What to Expect
Both medications have similar side effects, especially early on:
- Nausea
- Constipation or diarrhea
- Fatigue
- Bloating or gas
Zepbound may cause slightly more digestive discomfort due to its dual action, but many patients report that these effects decrease after the first few weeks.
5. Availability and Access
Ozempic has been on the market longer, so it’s more widely available in pharmacies. However, both are now accessible via telehealth platforms that ship directly to your home—no office visits or long wait times.
Providers like Meya offer:
- Free eligibility assessments
- Quick approvals
- Home delivery of your prescription
- Ongoing support and refill scheduling
Conclusion: Which One Is Better?
If you’re focused purely on weight loss, Zepbound (tirzepatide) offers superior results. But Ozempic (semaglutide) is still an excellent, well-studied option—especially for those sensitive to stronger medications.
The best choice depends on your goals, medical history, and budget. Either way, you don’t need to pay $1,400/month to get started.
Want real GLP-1 treatment without the $1,300/month price tag? Start with Meya for just $196/month.
